Literature DB >> 27994761

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity as an Inhibitor of Antiapoptotic Proteins.

Yuzhi Lu1, Shuangchan Wu1, Yuan Yue1, Si He1, Jun Li1, Jun Tang1, Wei Wang1, Hai-Bing Zhou1.   

Abstract

A series of gossypol Schiff bases that were derived from unnatural linear amino acid methyl esters were identified and found to be much more potent than gossypol and ABT-199 in terms of anticancer activity. This is the first example of gossypol Schiff bases with increased activity. The investigation of the Schiff base side chain of gossypol revealed that the unique anticancer effect was achieved by the introduction of hydrophobic ester groups. The optimized products showed low micromolar pan antitumor activities against NCI-60 tumor cell lines, which is promising for further drug development. Studies on the preliminary mechanism of action for their cellular activities was also carried out with antiapoptotic protein (Bcl-2 and Mcl-1) inhibition FP assays. The molecular modeling analysis demonstrated a possible binding mode for these compounds with Bcl-2, which could explain the binding affinity of the novel gossypol Schiff bases with these proteins.

Entities:  

Keywords:  Gossypol Schiff bases; antiapoptotic proteins; linear amino acid esters

Year:  2016        PMID: 27994761      PMCID: PMC5150665          DOI: 10.1021/acsmedchemlett.6b00302

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  31 in total

1.  Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins.

Authors:  Shinichi Kitada; Marilisa Leone; Sina Sareth; Dayong Zhai; John C Reed; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2003-09-25       Impact factor: 7.446

2.  Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.

Authors:  Guoping Wang; Zaneta Nikolovska-Coleska; Chao-Yie Yang; Renxiao Wang; Guozhi Tang; Jie Guo; Sanjeev Shangary; Su Qiu; Wei Gao; Dajun Yang; Jennifer Meagher; Jeanne Stuckey; Krzysztof Krajewski; Sheng Jiang; Peter P Roller; Hatice Ozel Abaan; York Tomita; Shaomeng Wang
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

Review 3.  BCL-2 family antagonists for cancer therapy.

Authors:  Guillaume Lessene; Peter E Czabotar; Peter M Colman
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694

4.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

5.  Synthesis and cytotoxicity of gossypol related compounds.

Authors:  V T Dao; C Gaspard; M Mayer; G H Werner; S N Nguyen; R J Michelot
Journal:  Eur J Med Chem       Date:  2000-09       Impact factor: 6.514

6.  Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.

Authors:  Y Hu; W H Dragowska; A Wallis; V Duronio; L Mayer
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

7.  Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism.

Authors:  Jian Yang; Gang Chen; Long Long Li; Wei Pan; Fang Zhang; Jingxiang Yang; Shuwen Wu; Po Tien
Journal:  Bioorg Med Chem Lett       Date:  2013-03-07       Impact factor: 2.823

8.  Polyphenols and health: current state and progress.

Authors:  Francisco A Tomás-Barberán; Cristina Andrés-Lacueva
Journal:  J Agric Food Chem       Date:  2012-05-17       Impact factor: 5.279

9.  A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy.

Authors:  W J Placzek; J Wei; S Kitada; D Zhai; J C Reed; M Pellecchia
Journal:  Cell Death Dis       Date:  2010-05-06       Impact factor: 8.469

10.  Differential dependence on Beclin 1 for the regulation of pro-survival autophagy by Bcl-2 and Bcl-xL in HCT116 colorectal cancer cells.

Authors:  Muriel Priault; Erika Hue; Fanny Marhuenda; Paul Pilet; Lisa Oliver; François M Vallette
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more
  2 in total

Review 1.  Recent advances of N-heterocyclic carbenes in the applications of constructing carbo- and heterocyclic frameworks with potential biological activity.

Authors:  Mei-Mei Li; Xiaozhen Chen; Yun Deng; Jun Lu
Journal:  RSC Adv       Date:  2021-11-26       Impact factor: 4.036

2.  Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins: Inducing apoptosis in cancer cells.

Authors:  Pawan Kumar Raghav; Rajesh Kumar; Vinod Kumar; Gajendra P S Raghava
Journal:  Mol Genet Genomic Med       Date:  2019-09-06       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.